Trial Profile
CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naive Patients Treated With Darunavir/Ritonavir and Etravirine
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Feb 2024
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Etravirine (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 07 Aug 2020 Results published in the AIDS
- 12 Sep 2017 Status changed from recruiting to discontinued.
- 08 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.